Effects of hyperoxia liquid on apoptosis by ischemia/reperfusion injury in rat

Xude Sun,Wei Chai,Changjun Gao,Guihe Zhang,Yonghui Yang,DeMing Peng,Hui Zhao,Lixian Xu
2003-01-01
Abstract:Aim. To observe the effects of intravenous hyperoxia liquid on the myocardial infarct size, myocardial ultrastructure, myocardial cell apoptosis and investigate the protective mechanism of hyperoxia liquid against ishemia/reperfusion(I/R) injury. Methods. Sixty SD rabbits were anesthetized with abdominal sodium pentobarbital, tracheotomized and mechanically ventilated. After 30 min ischemia and 2 hour reperfusion, the rabbits were randomly divided into 3 groups: control group(n=20) in which left anterior descending coronary artery was exposed and a piece of silk thread was placed around the artery but not tied; I/R group(n=20) in which normal saline (20 ml/kg) was injected into vein before I/R; hyperxia liquid group(n=20) which received intravenous hyperoxia liquid (20 ml/ kg) at 10min before I/R. The animals were then sacrificed and heart was harvested for determination of myocardial infarct size(by TTC) and ultrastructure examination (electron microscope). Apoptosis was identified by TUNEL and apoptosis index (AI) was obtained. The expression of Fas, Bcl-2 protein was measured by immunohistochemical ABC technique. Results. The infarct size of hyperxia liquid group was (2.29 ± 0.02) cm, significantly smaller than that of the I/R group [(3.38 ± 0.07)cm]. The apoptosis index was 20.8 ± 0.36 in the I/R group, significantly higher than in the control (4.1 ± 0.25) and hyperxia liquid (13.3 ± 0.35) groups respectively (P < 0.01, t = 170.4; P < 0.01, t = 66.8). The apoptosis of the hyperxia liquid group was significantly higher than that of the control group (P < 0.01, t = 92.8). The OD score of Fas protein was 2.80 ± 0.07, 3.70 ± 0.05, and 3.10 ± 0.04 in the control, I/R and hyperxia liquid groups respectively. The OD score of Bcl-2 protein was 2.7 ± 0.02, 0.60 ± 0.03 and 2.90 2+ 0.02 in the three groups respectively. Conclusions. Hyperoxia liquid protects myocardium from I/R injury by modulating the expression of Fas and Bcl-2 protein and inhibits apoptosis following myocardial I/R.
What problem does this paper attempt to address?